dr. (Arthur) AE Attema

All publications (56)

• Key publication (5)

  • A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2016). An elicitation of utility for quality of life under prospect theory. Journal of Health Economics, 48, 121-134. doi: 10.1016/j.jhealeco.2016.04.002
  • A.E. Attema, H. Bleichrodt, Y. Gao, Z. Huang & P.P. Wakker (2016). Measuring Discounting without Measuring Utility. The American Economic Review, 106 (6), 1476-1494. doi: 10.1257/aer.20150208
  • A.E. Attema, W.B.F. Brouwer & O. l'Haridon (2013). Prospect theory in the health domain: A quantitative assessment. Journal of Health Economics, 32, 1057-1065. doi: 10.1016/j.jhealeco.2013.08.006
  • A.E. Attema, H. Bleichrodt & P.P. Wakker (2012). A Direct Method for Measuring Discounting and QALYs more Easily and Reliably. Medical Decision Making, 32 (4), 583-593. doi: 10.1177/0272989X12451654
  • M. Abdellaoui, A.E. Attema & H. Bleichrodt (2010). Intertemporal tradeoffs for gains and losses: an experimental measurement of discounted utility. The Economic Journal, 120 (545), 845-866. doi: 10.1111/j.1468-0297.2009.02308.x

• Article (48)

  • Scholarly Publication (43)

    • A.E. Attema, H. Bleichrodt, O. l'Haridon & S.A. Lipman (2020). A comparison of individual and collective decision making for standard gamble and time trade-off. The European Journal Of Health Economics. doi: 10.1007/s10198-019-01155-x [go to publisher's site]
    • S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). QALYs without bias? Non-parametric correction of time trade-off and standard gamble weights based on prospect theory. Health Economics, 28 (7), 843-854. doi: 10.1002/hec.3895 [go to publisher's site]
    • S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). The corrective approach: policy implications of recent developments in QALY measurement based on prospect theory. Value in Health, 22 (7), 816-821. doi: 10.1016/j.jval.2019.01.013 [go to publisher's site]
    • A.E. Attema, L.S. He, A.J.C. Cook & V.J. Del Rio Vilas (2019). Unbiased assessment of disease surveillance utilities: a prospect theory application. PLoS Neglected Tropical Diseases (online), 13 (5):e0007364. doi: 10.1371/journal.pntd.0007364 [go to publisher's site]
    • A.E. Attema, O. l'Haridon & G. van de Kuilen (2019). Measuring multivariate risk preferences in the health domain. Journal of Health Economics, 64, 15-24. doi: 10.1016/j.jhealeco.2018.12.004 [go to publisher's site]
    • S.A. Lipman & A.E. Attema (2019). Rabin's Paradox for Health Outcomes. Health Economics, 28 (8), 1064-1071. doi: 10.1002/hec.3918 [go to publisher's site]
    • S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states. The European Journal Of Health Economics, 20 (3), 419-426. doi: 10.1007/s10198-018-1008-9 [go to publisher's site]
    • M.M. Versteegh, A.E. Attema & C.A. Uyl - de Groot (2019). Is verlies winst? Stoppen met TNF-α-blokkers. Nederlands Tijdschrift voor Geneeskunde.
    • A.E. Attema, H.M. Krol, N.J.A. van Exel & W.B.F. Brouwer (2018). New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. European Journal of Health Economics (HEPAC), 19 (2), 277-291. doi: 10.1007/s10198-017-0883-9
    • A.E. Attema & S.A. Lipman (2018). Decreasing impatience for health outcomes and its relation with healthy behavior. Frontiers in Applied Mathematics and Statistics, 4, 1-8. doi: 10.3389/fams.2018.00016
    • A.E. Attema, H. Bleichrodt, O. l'Haridon, P. Peretti-Watel & V. Seror (2018). Discounting health and money: New evidence using a more robust method. Journal of Risk and Uncertainty, 56 (2), 117-140. doi: 10.1007/s11166-018-9279-1
    • A.E. Attema, W.B.F. Brouwer & J.L. Pinto-Prades (2018). Peer effects in health valuation: The relation between rating of contemporaries' health and own health. Health and Quality of Life Outcomes, 16 (1):148. doi: 10.1186/s12955-018-0978-8
    • T. Rouyard, A.E. Attema, R. Baskerville, J. Leal & A. Gray (2018). Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory. Social Science & Medicine, 214, 144-153. doi: 10.1016/j.socscimed.2018.08.007
    • A.E. Attema, H. Bleichrodt & O. l'Haridon (2018). Ambiguity preferences for health. Health Economics, 27 (11), 1699-1716. doi: 10.1002/hec.3795
    • A.E. Attema, W.B.F. Brouwer & K. Claxton (2018). Discounting in economic evaluations. Pharmacoeconomics (Print), 36 (7), 745-758. doi: 10.1007/s40273-018-0672-z
    • M.F. Jonker, A.E. Attema, B. Donkers, E.A. Stolk & M.M. Versteegh (2017). Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment. Health Economics, 26 (12), 1534-1547. doi: 10.1002/hec.3445
    • C.J. Tilling, H.M. Krol, A.E. Attema, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2016). Exploring a new method for deriving the monetary value of a QALY. European Journal of Health Economics (HEPAC), 17 (7), 801-809. doi: 10.1007/s10198-015-0722-9
    • A.E. Attema, H. Bleichrodt, Y. Gao, Z. Huang & P.P. Wakker (2016). Measuring Discounting without Measuring Utility. The American Economic Review, 106 (6), 1476-1494. doi: 10.1257/aer.20150208
    • H.M. Krol, A.E. Attema, N.J.A. van Exel & W.B.F. Brouwer (2016). Altruistic preferences in TTO: Consideration of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198. doi: 10.1177/0272989X15615870
    • A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2016). An elicitation of utility for quality of life under prospect theory. Journal of Health Economics, 48, 121-134. doi: 10.1016/j.jhealeco.2016.04.002
    • A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2015). Estimating sign-dependent societal preferences for quality of life. Journal of Health Economics, 43, 229-243. doi: 10.1016/j.jhealeco.2015.07.006
    • A.E. Attema (2015). Incorporating sign-dependence in health-related social welfare functions. Expert review of pharmacoeconomics & outcomes research, 15 (2), 223-228. doi: 10.1586/14737167.2015.995170
    • A.E. Attema & W.B.F. Brouwer (2014). Deriving time discounting correction factors for TTO tariffs. Health Economics, 23 (4), 410-425. doi: 10.1002/hec.2921
    • A.E. Attema, W.B.F. Brouwer & N.J.A. van Exel (2014). Your right arm for a publication in AER? Economic Inquiry, 52 (1), 495-502. doi: 10.1111/ecin.12013
    • A.E. Attema & M.M. Versteegh (2013). Would you rather be ill now, or later? Health Economics, 22 (12), 1496-1506. doi: 10.1002/hec.2894
    • A.E. Attema, Y. Edelaar-Peeters, M.M. Versteegh & E.A. Stolk (2013). Time trade-off: one methodology, different methods. European Journal of Health Economics (HEPAC), 14 (1), 53-64. doi: 10.1007/s10198-013-0508-x
    • M.M. Versteegh, A.E. Attema, M. Oppe, N. Devlin & E.A. Stolk (2013). Time to tweak the TTO: results from a comparison of alternative specifications of the TTO. European Journal of Health Economics (HEPAC), 14 (1), 43-51. doi: 10.1007/s10198-013-0507-y
    • A.E. Attema & W.B.F. Brouwer (2013). In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks. Journal of Economic Psychology, 39, 126-140. doi: 10.1016/j.joep.2013.07.009
    • A.E. Attema, M.M. Versteegh, M. Oppe, W.B.F. Brouwer & E.A. Stolk (2013). LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS. Health Economics, 22 (4), 376-392. doi: 10.1002/hec.2804
    • A.E. Attema, W.B.F. Brouwer & O. l'Haridon (2013). Prospect theory in the health domain: A quantitative assessment. Journal of Health Economics, 32, 1057-1065. doi: 10.1016/j.jhealeco.2013.08.006
    • A.E. Attema & W.B.F. Brouwer (2012). The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design. The European Journal Of Health Economics, 13, 491-500. doi: 10.1007/s10198-011-0318-y
    • A.E. Attema, H. Bleichrodt & P.P. Wakker (2012). A Direct Method for Measuring Discounting and QALYs more Easily and Reliably. Medical Decision Making, 32 (4), 583-593. doi: 10.1177/0272989X12451654
    • A.E. Attema (2012). Developments in time preference and their implications for medical decision making. European Journal of Operational Research, 63 (10), 1388-1399. doi: 10.1057/jors.2011.137
    • A.E. Attema & W.B.F. Brouwer (2012). Constantly Proving The Opposite? A test of CPTO using a broad time horizon and correcting for discounting. Quality of Life Research, 21 (1), 25-34. doi: 10.1007/s11136-011-9917-4
    • A.E. Attema & W.B.F. Brouwer (2012). A test of indepence of discounting from quality of life. Journal of Health Economics, 31, 22-34. doi: 10.1016/j.jhealeco.2011.12.001
    • A.E. Attema, H. Bleichrodt, K.I.M. Rohde & P.P. Wakker (2010). Time-Tradeoff Sequences for Analyzing Discounting and Time Inconsistency. Management Science, 56 (11), 2015-2030. doi: 10.1287/mnsc.1100.1219
    • A.E. Attema, A.K. Lugnér & T.L. Feenstra (2010). Investment in antiviral drugs: a real options approach. Health Economics, 19, 1240-1254. doi: 10.1002/hec.1549
    • A.E. Attema & W.B.F. Brouwer (2010). On the (not so) constant proportional trade-off in TTO. Quality of Life Research, 19, 489-497. doi: 10.1007/s11136-010-9605-9
    • M. Abdellaoui, A.E. Attema & H. Bleichrodt (2010). Intertemporal tradeoffs for gains and losses: an experimental measurement of discounted utility. The Economic Journal, 120 (545), 845-866. doi: 10.1111/j.1468-0297.2009.02308.x
    • A.E. Attema & W.B.F. Brouwer (2010). The Value of Correcting Values: Influence and Importance of Correcting TTO Scores for Time Preference. Value in Health, 13 (8), 879-884. doi: 10.1111/j.1524-4733.2010.00773.x
    • A.E. Attema & W.B.F. Brouwer (2009). The correction of TTO-scores for utility curvature using a risk-free utility elicitation method. Journal of Health Economics, 28, 234-243. doi: 10.1016/j.jhealeco.2008.10.004
    • A.E. Attema & W.B.F. Brouwer (2008). Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. Health Economics, 17, 877-885. doi: 10.1002/hec.1315
    • A.E. Attema (2006). Measuring pronesess to arbitrage using only pencil and paper. Medium Econometrische Toepassingen, 14 (4).

  • Professional Publication (5)

    • M.M. Versteegh, A.E. Attema & C.A. Uyl - de Groot (2019). Is verlies winst? Stoppen met TNF-alfaremmers. Nederlands Tijdschrift voor Geneeskunde, 163:D3709. [go to publisher's site]
    • A.E. Attema (2017). Economische inzichten in stimulatie van gezond gedrag: de voor- en nadelen van een financiële prikkel. Nederlands Tijdschrift voor Geneeskunde, 161:D1933. [go to publisher's site]
    • A.E. Attema (2017). De meting van maatschappelijke voorkeuren voor gezondheid(szorg) vanuit een gedragseconomisch perspectief. TPEdigitaal, 11 (2), 36-48.
    • A.E. Attema (2009). De TTO-methode en correctie voor tijdsvoorkeur. VGE Bulletin, 2 (26), 14-17.
    • A.E. Attema (2008). De rol van tijdsvoorkeur bij de waardering van gezondheid. TPEdigitaal, 2 (4), 92-105.

• Part of book - Chapter (2)

  • J.L. Pinto-Prades, A.E. Attema & F.I. Sanchez-Martinez (2019). Measuring Health Utility in Economics. In Oxford Research Encyclopedia of Economics and Finance. Oxford: Oxford University Press [go to publisher's site]
  • A.E. Attema & W.B.F. Brouwer (2014). Constant proportional trade-offs and health state evaluations. In AC Michalos (Ed.), Encyclopedia of Quality of Life and Well-Being Research (pp. 1207-1212). Dordrecht: Springer

• Doctoral thesis (1)

  • A.E. Attema (2008, januari 25). Studies on intertemporral preferences with applications to health economics. EUR (254 pag.) (Rotterdam) Prom./coprom.: prof.dr. H. Bleichrodt & prof.dr. P.P. Wakker.

Teaching (3)

Editorial positions (16)

Present position